1440 Results

People

  1. Old
    Old
  2. Cheung
    Cheung
  3. Scheinberg
    Scheinberg
  4. Cordon-Cardo
    Cordon-Cardo
  5. Larson
    Larson
  6. Houghton
    Houghton
  7. Lloyd
    Lloyd
  8. Divgi
    Divgi
  9. Finn
    Finn
  10. Kushner
    Kushner

Groups

  1. Department of Medicine (624)
  2. GSK Faculty (402)
  3. Solid Tumor Oncology Division (377)
  4. Sloan Kettering Institute Faculty (278)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (276)
  6. Hematologic Malignancies, Division of (259)
  7. Tow Center for Developmental Oncology (TCDO) (246)
  8. Center for Hematologic Malignancies (220)
  9. Molecular Pharmacology and Chemistry Program Faculty (208)
  10. Center for Molecular Imaging and Biotechnology (196)
  1. "monoclonal antibody"
Formats
  1. Journal Article (1303)
  2. Conference Paper (39)
  3. Review (36)
  4. Research Letter (27)
  5. Meeting Abstract (17)
  6. Editorial (6)
  7. Correspondence (5)
  8. Guidelines (4)
  9. Book Section (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (624)
  2. GSK Faculty (402)
  3. Solid Tumor Oncology Division (377)
  4. Sloan Kettering Institute Faculty (278)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (276)
  6. Hematologic Malignancies, Division of (259)

More Groups

People
  1. Lloyd Old (131)
  2. Nai-Kong Cheung (128)
  3. Steven Larson (94)
  4. David Scheinberg (88)
  5. Carlos Cordon-Cardo (61)
  6. Alan Houghton (50)

More People

Years
  1. 2025 (26)
  2. 2024 (93)
  3. 2023 (58)
  4. 2022 (52)
  5. 2021 (14)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (84)
  2. Clinical Cancer Research (63)
  3. Cancer Research (61)
  4. Journal of Nuclear Medicine (37)
  5. Blood (35)
  6. New England Journal of Medicine (31)

More Publications

Publishers
  1. American Association for Cancer Research (133)
  2. Elsevier Inc. (130)
  3. Springer (91)
  4. American Society of Clinical Oncology (87)
  5. Nature Publishing Group (68)
  6. Lippincott Williams & Wilkins (65)

More Publishers

Results (1440)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enfortumab vedotin and pembrolizumab: Redefining the standard of care for previously untreated advanced urothelial cancer
    Review

    Sternschuss, M.; Rosenberg, J. E.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Predictors of pathologic complete response with neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer
    Journal Article

    Perry, L. M.; Sevilimedu, V.; Polidorio, N.; Abuhadra, N.; Morrow, M.; Plitas, G.; Downs-Canner, S.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Emerging importance of HER3 in tumorigenesis and cancer therapy
    Review

    Garrett, J. T.; Tendler, S.; Feroz, W.; Kilroy, M. K.; Yu, H.
    Nature Reviews Clinical Oncology (2025)

    Fulltext@MSK | Save
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
    Journal Article

    Sethna, Z.; Guasp, P.; Reiche, C.; Milighetti, M.; Ceglia, N.; Patterson, E.; Lihm, J.; Payne, G.; Lyudovyk, O.; Rojas, L. A.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes: MULTIPLE MYELOMA, GAMMOPATHIES
    Journal Article

    Facon, T.; Moreau, P.; Weisel, K.; Goldschmidt, H.; Usmani, S. Z.; Chari, A.; Plesner, T.; Orlowski, R. Z.; Bahlis, N.; Basu, S.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Sustained improvement in health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone: MAIA final analysis of patient-reported outcomes
    Journal Article

    Perrot, A.; Facon, T.; Plesner, T.; Usmani, S. Z.; Kumar, S.; Bahlis, N. J.; Hulin, C.; Orlowski, R. Z.; Nahi, H.; Mollee, P.; more...
    European Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: Final analysis of the phase III JAVELIN Renal 101 trial
    Journal Article

    Choueiri, T. K.; Penkov, K.; Uemura, H.; Campbell, M. T.; Pal, S.; Kollmannsberger, C.; Lee, J. L.; Venugopal, B.; van den Eertwegh, A. J. M.; Negrier, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Biomarker analyses from the phase III randomized CLEAR trial: Lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Grünwald, V.; George, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • IL13Rα2-targeting antibodies for immuno-PET in solid malignancies
    Journal Article

    Gajecki, L.; Lebedeva, I. V.; Liao, Y. R.; Ambriz, D.; Carter, L. M.; Kumpf, M.; Lovibond, S.; Hachey, J. S.; Graham, M. S.; Postow, M.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save